Total Payments
$97,704
2024 Payments
$56,950
Companies
13
Transactions
133
Medicare Patients
168
Medicare Billing
$24,765
Payment Breakdown by Category
Consulting$49,734 (50.9%)
Other$33,406 (34.2%)
Travel$8,326 (8.5%)
Food & Beverage$6,238 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $49,734 | 13 | 50.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,406 | 12 | 34.2% |
| Travel and Lodging | $8,326 | 18 | 8.5% |
| Food and Beverage | $6,238 | 90 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $30,875 | 22 | $0 (2024) |
| EMD Serono, Inc. | $27,309 | 44 | $0 (2024) |
| TG Therapeutics, Inc. | $21,260 | 20 | $0 (2024) |
| GENZYME CORPORATION | $12,802 | 15 | $0 (2024) |
| Amgen Inc. | $3,334 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,129 | 11 | $0 (2024) |
| Horizon Therapeutics plc | $292.35 | 3 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $219.76 | 2 | $0 (2021) |
| Roche Products Limited | $126.25 | 1 | $0 (2024) |
| Banner Life Sciences, LLC | $124.87 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,950 | 71 | EMD Serono, Inc. ($26,859) |
| 2023 | $27,808 | 35 | GENZYME CORPORATION ($12,550) |
| 2022 | $7,876 | 14 | Genentech USA, Inc. ($7,444) |
| 2021 | $2,690 | 10 | Genentech USA, Inc. ($2,060) |
| 2020 | $2,380 | 3 | Genentech USA, Inc. ($2,293) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $112.51 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $7,590.00 | General |
| Category: Immunology | ||||||
| 11/13/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: Neurology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $77.14 | General |
| Category: Neurology | ||||||
| 11/07/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $124.49 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $118.42 | General |
| 10/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | In-kind items and services | $483.96 | General |
| Category: Immunology | ||||||
| 09/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $1,757.16 | General |
| Category: Neurology | ||||||
| 09/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $782.95 | General |
| Category: Neurology | ||||||
| 09/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $366.35 | General |
| Category: Neurology | ||||||
| 09/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.69 | General |
| 09/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | In-kind items and services | $483.96 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $143.82 | General |
| Category: Immunology | ||||||
| 08/26/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,488.00 | General |
| Category: Neurology | ||||||
| 08/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $1,688.00 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $64.66 | General |
| Category: Neurology | ||||||
| 08/07/2024 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $55.34 | General |
| Category: Neurology | ||||||
| 07/31/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $1,013.00 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/16/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $124.13 | General |
| Category: Neurology | ||||||
| 06/28/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,843.00 | General |
| Category: Neurology | ||||||
| 06/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $465.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 79 | 123 | $62,496 | $11,260 |
| 2022 | 4 | 89 | 158 | $71,130 | $13,505 |
Total Patients
168
Total Services
281
Medicare Billing
$24,765
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 49 | 84 | $46,452 | $8,432 | 18.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $13,356 | $2,382 | 17.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 12 | 21 | $2,688 | $446.50 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 34 | 70 | $37,590 | $7,521 | 20.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 34 | $16,116 | $2,639 | 16.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 18 | 18 | $12,960 | $2,478 | 19.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 19 | 36 | $4,464 | $866.40 | 19.4% |
About Sam Hooshmand
Sam Hooshmand is a Neurology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1417310665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sam Hooshmand has received a total of $97,704 in payments from pharmaceutical and medical device companies, with $56,950 received in 2024. These payments were reported across 133 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($49,734).
As a Medicare-enrolled provider, Hooshmand has provided services to 168 Medicare beneficiaries, totaling 281 services with total Medicare billing of $24,765. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Milwaukee, WI
- Active Since 04/04/2016
- Last Updated 06/03/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1417310665
Products in Payments
- Mavenclad (Drug) $22,496
- BRIUMVI (Drug) $21,260
- Ocrevus (Biological) $18,808
- OCREVUS (Biological) $9,629
- UPLIZNA (Biological) $3,334
- Enspryng (Biological) $2,187
- KESIMPTA (Drug) $614.39
- UPLIZNA (Drug) $292.35
- AUBAGIO (Drug) $244.19
- Ocrevus Zunovo (Biological) $143.82
- BAFIERTAM (Drug) $124.87
- ZEPOSIA (Drug) $95.00
- Soliris (Drug) $94.76
- GILENYA (Drug) $55.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Milwaukee
Dr. Bhupendra Khatri, M.d, M.D
Neurology — Payments: $3.6M
Neurology $3.6M
Staley Brod, M.d, M.D
Neurology — Payments: $1.4M
Neurology $1.4M
Joseph Burgarino, M.d, M.D
Neurology — Payments: $143,112
Neurology $143,112
Fallon Schloemer, D.o, D.O
Neurology — Payments: $48,507
Neurology $48,507
Ryan Brennan, D.o, D.O
Neurology — Payments: $27,544
Neurology $27,544
George Morris, Md, MD
Neurology — Payments: $20,214
Neurology $20,214